A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies.

MLA

Bossuyt, Xavier, et al. “A Multicentre Study to Improve Clinical Interpretation of Proteinase-3 and Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibodies.” Rheumatology (Oxford, England), vol. 56, no. 9, Sept. 2017, pp. 1533–41. EBSCOhost, https://doi.org/10.1093/rheumatology/kex170.

APA

Bossuyt, X., Rasmussen, N., van Paassen, P., Hellmich, B., Baslund, B., Vermeersch, P., Blockmans, D., Cohen Tervaert, J.-W., Csernok, E., & Damoiseaux, J. (2017). A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies. Rheumatology (Oxford, England), 56(9), 1533–1541. https://doi.org/10.1093/rheumatology/kex170

Chicago

Bossuyt, Xavier, Niels Rasmussen, Pieter van Paassen, Bernard Hellmich, Bo Baslund, Pieter Vermeersch, Daniel Blockmans, Jan-Willem Cohen Tervaert, Elena Csernok, and Jan Damoiseaux. 2017. “A Multicentre Study to Improve Clinical Interpretation of Proteinase-3 and Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibodies.” Rheumatology (Oxford, England) 56 (9): 1533–41. doi:10.1093/rheumatology/kex170.